The investor pages that follow are your resource for financial information about Oculus Innovative Sciences, Inc.. In this section you will find information about our current and historical share price, SEC filings and frequently asked questions as well as forms to request additional information.

Recent Releases

Jun 24, 2009
Second U.S. Independent Laboratory Confirms that Oculus Innovative Sciences' Microcyn® Technology Effective at Inactivating H1N1 Swine Flu

Jun 19, 2009
Oculus Innovative Sciences Announces Preliminary Results From 40-Patient Feasibility Study for Treatment of Acne With Enhanced Microcyn® Hydrogel Formulation

Jun 11, 2009
Oculus Innovative Sciences Reports FY 2009 Financial Results and Discusses Worldwide Revenue Growth Prospects

more »

Forward-Looking Statements
This website contains forward-looking statements based on certain assumptions and expectations. For this purpose, any statements contained in this website that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "intends" and similar expressions are intended to identify forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties relating to our product development, success of clinical trials, obtaining the requisite regulatory approvals, market acceptance of our product, our ability to protect our intellectual property and future financial results. For a discussion of other factors that may cause Oculus’ actual results to differ from those projected, expressed or implied by the forward looking statements, please refer to the Company's Registration Statement on Form S-1 as well as other subsequent filings with the Securities and Exchange Commission. We do not undertake, and specifically disclaim any obligation, to revise any forward looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements.